#Ireland #Medtronic #Galway #Merit Medical #ViaVerte

Medtronic Partners with Merit Medical to Enhance Chronic Pain Treatment

Medtronic plc, a prominent name in healthcare technology, has announced a new collaborative agreement with Merit Medical Systems, Inc. This collaboration unveils the FDA-approved ViaVerte™ system, designed specifically for treating chronic vertebrogenic lower back pain through a novel basivertebral nerve ablation (BVNA) method.

Introduction to the ViaVerte™ System

The ViaVerte™ system stands out due to its innovative design as the first-ever implant-free BVNA system that utilizes a physician-controlled steerable mechanism. This allows for accurate targeting of the basivertebral nerve, which is essential for managing chronic lower back pain. With a growing number of Americans facing chronic pain—statistics from the American Chronic Pain Association cite that approximately one in three Americans experience chronic discomfort—ViaVerte™ presents a valuable option for effective pain management.

Due to its minimally invasive nature, the ViaVerte™ system facilitates an outpatient procedure, enabling patients to undergo treatment and return home the same day. The anticipated access to this cutting-edge procedure is expected later this year, augmenting Medtronic's commitment to advancing healthcare solutions.

Strengthening Medtronic’s Commitment to Pain Management

This strategic partnership marks a significant milestone for Medtronic in its efforts to enhance its global pain management portfolio. The synergy between Medtronic and Merit Medical, previously established through the supply of Medtronic's Kyphon™ products for balloon kyphoplasty, highlights the companies' shared commitment to innovating patient care.

Paolo Di Vincenzo, president of Medtronic Neuromodulation, emphasized the importance of this new collaboration: "For 50 years, we have pushed the boundaries of chronic pain treatment, and with ViaVerte™, we bring even more substantial options for patients seeking lasting relief."

Michael Blackham, executive vice president at Merit Medical Systems, expressed excitement over the collaboration, citing the technology as a pivotal enhancement in the BVNA sector. Both companies are working in tandem to implement solutions that bolster physician assistance and improve patient care.

Expanding Treatment Options

Medtronic's diverse portfolio includes various pain management therapies such as spinal cord stimulation, nerve ablation, vertebral augmentation, and targeted drug deliverance. The addition of the ViaVerte™ system is a critical response to the increasing need for advanced treatment alternatives for chronic pain, particularly those associated with vertebral endplate damage.

This partnership is not solely about introducing a new product; it reflects a broader ambition to address patient needs comprehensively. With a remarkable increase in the demand for innovative therapies, the ViaVerte™ system aims to offer an effective solution alongside existing Medtronic offerings.

About Medtronic and Merit Medical

Founded in 1949, Medtronic is headquartered in Galway, Ireland. It is a leader in healthcare technology, driven by a mission to alleviate pain, restore health, and extend life. The company operates globally, providing solutions that tackle health issues threatening humanity. With over 95,000 employees committed to research and development, Medtronic has a track record of transforming lives through its technological advancements.

Merit Medical Systems, founded in 1987, is recognized for developing proprietary medical devices for various interventional procedures, including cardiology and oncology. With a dedicated workforce of more than 7,600 globally, Merit focuses on delivering high-quality, innovative medical solutions.

Together, the collaboration between Medtronic and Merit Medical represents a significant stride toward enhancing the landscape of chronic pain treatment, providing hope and relief to countless individuals suffering from debilitating pain conditions.